GRTS · Gritstone Oncology
Acquired Company
Seattle Project Corp completed the acquisition of substantially all of the assets of Gritstone bio, Inc. on December 30, 2024.
Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California.
5959 HORTON STREET, EMERYVILLE, CA, UNITED STATES, 94608, California, 94608-2006, USA
BIOTECHNOLOGY
HEALTHCARE
Market Cap
3.803M
52 Wk Range
$0.00 - $0.00
Previous Close
$0.03
Open
$0.03
Volume
N/A
Day Range
$0.03 - $0.03
Enterprise Value
N/A
Cash
52.17M
Avg Qtr Burn
-26.81M
Insider Ownership
1.91%
Institutional Own.
29.03%
Qtr Updated
Jun 30th 2024